Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60
Published March 13, 2024 · Recall initiated: February 20, 2024
Summary
FDA records drug Class III recall D-0365-2024, published March 13, 2024 and initiated February 20, 2024. Recalling firm: Contract Pharmaceuticals Limited Canada; Status: Ongoing; Reported quantity: 11,750 bottles; Lot: Lot #: 119874; Exp 06/30/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Contract Pharmaceuticals Limited Canada
- Distributor
- Nationwide in the U.S. and Puerto Rico
- Lot
- Lot #: 119874; Exp 06/30/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Canada
Related recalls
- FDAClindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: MarlexMarch 13, 2024
- FDAMethylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, RxMarch 13, 2024
- FDAMercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottleMarch 13, 2024
- FDALINK BiMobile Dual Mobility System E-Poly Liner for 28mm Head, 70mm Shell- Indicated for patients withMarch 6, 2024
- FDAAcu-Loc and Acu-Loc 2 bone plates, screws and accessories for the following REF: 70-0045 Acu-Loc VDU PlateMarch 6, 2024
- FDAClindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: ContractSeptember 6, 2023
Questions about this recall
Was Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60 recalled?
Yes. FDA published recall D-0365-2024 on March 13, 2024. Reported hazard: Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
What should I do if I have this product?
Voluntary: Firm initiated · Letter